APTALIS PHARMA INC Capital Expenditures
APTALIS PHARMA INC reported Capital Expenditures of $4.33 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2012-02-10
- APTALIS PHARMA INC payments to acquire property, plant, and equipment for the quarter ending 2011-12-31 was $4.33M, a 281.59% increase year-over-year.
- APTALIS PHARMA INC payments to acquire property, plant, and equipment for the quarter ending 2011-09-30 was $2.09M, a 112.06% increase year-over-year.
- APTALIS PHARMA INC payments to acquire property, plant, and equipment for the quarter ending 2010-12-31 was $1.14M.
- APTALIS PHARMA INC payments to acquire property, plant, and equipment for the quarter ending 2010-09-30 was $987.00K.
- APTALIS PHARMA INC payments to acquire property, plant, and equipment for fiscal 2011 was $7.41M, a 22.28% increase from fiscal 2010.
- APTALIS PHARMA INC payments to acquire property, plant, and equipment for fiscal 2010 was $6.06M, a 42.80% decline from fiscal 2009.
- APTALIS PHARMA INC payments to acquire property, plant, and equipment for fiscal 2009 was $10.59M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2011-12-31 | $4.33M 10-Q · filed 2012-02-10 | $6.42M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2011-09-30 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $7.41M 10-K · filed 2011-12-20 | ||
| 2011-06-30 | $5.32M 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | $1.14M 10-Q · filed 2012-02-10 | $2.12M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2010-09-30 | $987.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $6.06M 10-K · filed 2011-12-20 | ||
| 2010-06-30 | $5.07M 10-Q · filed 2011-08-12 | |||
| 2009-09-30 | $10.59M 10-K · filed 2011-12-20 |